US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invesco Floating Rate Municipal Income ETF

24.87

+0.00500.02%

Post-market: 24.86-0.0100-0.04%16:04 EDT

Volume:670.00

Turnover:16.64K

Market Cap:31.09M

PE:- -

High:24.87

Open:24.85

Low:24.79

Close:24.87

Loading ...

Overview Company News Filings

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

Microbot Medical announces ACCESS-PVI trial met primary endpoint

REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

ABT Stock to Gain From Early CE Mark Approval of Volt PFA System

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Skunk Works® Demonstrates Airborne Battle Management of AI-Controlled Aircraft

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PVI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","market":"US","secType":"STK","nameCN":"Invesco Floating Rate Municipal Income ETF","latestPrice":24.87,"timestamp":1750276800000,"preClose":24.865,"halted":0,"volume":670,"hourTrading":{"tag":"盘后","latestPrice":24.86,"preClose":24.87,"latestTime":"16:04 EDT","volume":3,"amount":74.61,"timestamp":1750277046845},"delay":0,"floatShares":1250000,"shares":1250000,"eps":0,"marketStatus":"Closed Juneteenth National Independence Day","change":0.005,"latestTime":"06-18 16:00:00 EDT","open":24.85,"high":24.87,"low":24.79,"amount":16640.54,"amplitude":0.003217,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":24.865,"sharesOutstanding":1250000,"nav":24.84976,"aum":31062200,"dividendRate":0.02493,"bidAskSpread":0.003965,"postHourTrading":{"tag":"盘后","latestPrice":24.86,"preClose":24.87,"latestTime":"16:04 EDT","volume":3,"amount":74.61,"timestamp":1750277046845},"volumeRatio":0.5800866704896975},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVI\",,,,,undefined,":{"symbol":"PVI","floatShares":1250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5800866704896975,"shares":1250000,"dividePrice":0.62,"high":24.87,"amplitude":0.003217,"preClose":24.865,"low":24.79,"week52Low":24.34,"pbRate":"--","week52High":25.37,"institutionHeld":0,"latestPrice":24.87,"eps":0,"divideRate":0.02493,"volume":670,"delay":0,"ttmEps":0,"open":24.85,"prevYearClose":24.71,"prevWeekClose":24.82,"prevMonthClose":24.85,"prevQuarterClose":24.825,"fiveDayClose":24.855,"twentyDayClose":24.789,"sixtyDayClose":24.835},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530117041","title":"Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2530117041","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530117041?lang=en_us&edition=fundamental","pubTime":"2025-04-27 07:20","pubTimestamp":1745709600,"startTime":"0","endTime":"0","summary":"One-year clinical trial data for the next-generation, investigational, Sphere-360 single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib. Dual-energy , focal Sphere-9 catheter demonstrates efficacy for linear ablation in persistent AFib. Medtronic continues legacy of leadership in innovation, showcasing arrhythmia management portfolio at Heart Rhythm Society annual meeting. GALWAY, Ireland and SAN DIEGO, April 26, 2025 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation  patients treated with the Affera family of technologies, including the next-generation Sphere-360 single-shot pulsed field ablation  catheter and the groundbreaking Sphere-9 combination mapping and dual-energy focal PFA catheter. Data were presented in High Impact Science Sessions at the Heart Rhythm Society 2025 Annual Meeting in San Diego; the Sphere-360 study was ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medtronic-affera-pulsed-field-ablation-232000945.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medtronic-affera-pulsed-field-ablation-232000945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","IE00BFXG1179.USD","LU1989771016.USD","LU1983299246.USD","PAF","BK4082","IE00BQXX3F31.USD","LU0320765489.SGD","LU1116320901.HKD","IE00BQXX3C00.GBP","BK4588","BK4533","LU0265550359.USD","LU2271345857.HKD","LU2468319806.SGD","IE00B3T34201.USD","LU0265550946.USD","LU2111349929.HKD","IE000M9KFDE8.USD","LU1571399168.USD","LU0976567544.SGD","LU1989764664.SGD","LU1989764748.USD","LU2089984988.USD","BK4566","LU0158827781.USD","LU0211326755.USD","LU0208291251.USD","BK4585","LU0496365809.HKD","LU1291159041.SGD","MDT","LU0158827948.USD","IE00BQXX3D17.EUR","LU2089284900.SGD","LU2023251221.USD","LU1116320737.USD","PVI","LU0070302665.USD","LU0072461881.USD","LU2089283258.USD","LU0162691827.USD","LU2028103732.USD","LU0211326839.USD"],"gpt_icon":0},{"id":"2526366528","title":"Microbot Medical announces ACCESS-PVI trial met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366528","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366528?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:37","pubTimestamp":1744202222,"startTime":"0","endTime":"0","summary":"Microbot Medical (MBOT) presented for the first time the data from its ACCESS-PVI pivotal trial at the Society of Interventional Radiology annual m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/microbot-medical-announces-access-pvi-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/microbot-medical-announces-access-pvi-trial-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBOT","PVI","BK4082"],"gpt_icon":0},{"id":"2524115783","title":"REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2524115783","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524115783?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:30","pubTimestamp":1743510600,"startTime":"0","endTime":"0","summary":"Company Reaffirms Expected Timing of FDA Decision With Respect to 510 Clearance of LIBERTY During the Current Second Quarter. BRAINTREE, Mass., April 01, 2025  -- Microbot Medical Inc. , developer of the innovative LIBERTY Endovascular Robotic System, is providing this reminder that data from the Company’s ACCESS-PVI trial will be presented by Francois Cornelis, MD, PhD, FCIRSE, Memorial Sloan Kettering Cancer Center, Department of Radiology. This is the first time data from the study will be presented via a podium presentation, to take place on Wednesday, April 2, 11:33am CT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reminder-microbot-medical-announces-data-123000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["K","BK4212","BK4082","BK4588","MBOT","BK4504","BK4585","PVI"],"gpt_icon":0},{"id":"2524110878","title":"ABT Stock to Gain From Early CE Mark Approval of Volt PFA System","url":"https://stock-news.laohu8.com/highlight/detail?id=2524110878","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524110878?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:27","pubTimestamp":1743510420,"startTime":"0","endTime":"0","summary":"Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation  system to treat patients battling atrial fibrillation . The development came earlier than expected, allowing the company to begin commercial PFA cases in the European Union  with physicians who have already gained experience with the Volt PFA system within its PFA clinical studies.The company will further expand the use of Volt in EU markets throughout the second half of this year.After the announcement on March 27, Abbott shares rose 3.7%, closing at $131.35. The company’s EP portfolio has been seeing well-balanced growth across the United States and international markets. The introduction of the Volt PFA system marks a pivotal moment for electrophysiology in Europe. We expect the market sentiment toward ABT stock to remain positive surrounding this development.Abbott holds a market capitalization of $226.88 billion. The company’s earnings yield of 3.9% surpasses the industry’s average yield of 0.3%. AB","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abt-stock-gain-early-ce-122700836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2506951875.HKD","BK4213","BK4196","LU0310800965.SGD","LU1989764664.SGD","LU1989764748.USD","LU1914381329.SGD","LU1989771016.USD","LU2362541513.USD","LU1023059063.AUD","BK4109","LU0011850046.USD","IE00BJT1NW94.SGD","LU0154236417.USD","LU1983299246.USD","LU0266013472.USD","LU2468319806.SGD","LU1291159041.SGD","LU0211327993.USD","LU0889566641.SGD","LU0950375773.USD","ABT","LU1989772923.USD","LU1267930490.SGD","LU0345769631.USD","LU1691799644.USD","LU1153585028.USD","LU2506952170.USD","PVI","LU2089984988.USD","LU0225283273.USD","LU1061106388.HKD","BK4175","LU2112291526.USD","LU1267930813.SGD","LU0187121727.USD","LU1267930227.SGD","EP","CAH","LU2506951958.HKD","CE","LU0353189763.USD","LU2133065610.SGD","LU2362540622.SGD","LU1571399168.USD","BSX","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU2244417387.USD"],"gpt_icon":1},{"id":"2522306934","title":"Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms","url":"https://stock-news.laohu8.com/highlight/detail?id=2522306934","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522306934?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:00","pubTimestamp":1743080400,"startTime":"0","endTime":"0","summary":"Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation. Pulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heart. Abbott's Volt PFA System is designed to overcome limitations of existing PFA systems, providing improved workflows and a clearer indication of contact between the Volt PFA catheter and targeted tissue. ABBOTT PARK, Ill., March 27, 2025 /PRNewswire/ -- Abbott  today announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation . With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies. The company will further expand use of Volt in EU markets throughout the second half of the year.Volt PFA Syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/abbott-receives-ce-mark-volt-130000876.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbott-receives-ce-mark-volt-130000876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B2B36J28.USD","IE0009355771.USD","LU1057294990.SGD","LU1023059063.AUD","LU2133065610.SGD","ABT","LU1989763427.SGD","SGXZ23171101.USD","LU1721429741.USD","BK4568","IE00BJT1NW94.SGD","LU0868494617.USD","LU2237957902.USD","BK4213","BK4588","CE","IE00BJJMRZ35.SGD","IDE","BK4566","BK4592","PVI","BK4109","LU2468319806.SGD","SG9999002232.USD","BK4585","LU0122379950.USD","LU1061106388.HKD","LU2089984988.USD","LU1914381329.SGD","SG9999002224.SGD","LU0266013472.USD","LU1691799644.USD","LU1989763690.USD","LU2237957811.SGD","SG9999004303.SGD","LU0234572021.USD","LU1721429402.USD","LU0170899867.USD","IE0002141913.USD","BK4082","BK4581","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","BK4504","EP","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2505187229","title":"Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2505187229","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505187229?lang=en_us&edition=fundamental","pubTime":"2025-01-21 20:00","pubTimestamp":1737460800,"startTime":"0","endTime":"0","summary":"Successfully treated atrial fibrillation  in initial 30 patients with the Nanosecond PFA 360° Cardiac Catheter. MIAMI, January 21, 2025----Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation  technology, today announced the late-breaking data from its Nanosecond PFA 360° Cardiac Catheter System first-in-human feasibility study, which data were recently presented at the 30th Annual AF Symposium 2025 meeting.\"We appreciate the support of the renowned EPs who are performing the initial clinical work with our catheter ablation system and are presenting its clinical performance to their peers in the scientific community. We believe nanosecond PFA represents the next generation energy modality that will improve the safety, efficacy and efficiency of AF ablation through a more straightforward and clinician-friendly procedure,\" said Paul LaViolette, CEO and Co-Chairman of Pulse Biosciences. \"We remain on track to begin an IDE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pulse-biosciences-announces-breaking-data-120000787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PLSE","PVI","BK4082"],"gpt_icon":0},{"id":"2485134443","title":"Skunk Works® Demonstrates Airborne Battle Management of AI-Controlled Aircraft","url":"https://stock-news.laohu8.com/highlight/detail?id=2485134443","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485134443?lang=en_us&edition=fundamental","pubTime":"2024-11-22 01:00","pubTimestamp":1732208400,"startTime":"0","endTime":"0","summary":"IOWA CITY, Iowa, Nov. 21, 2024 /PRNewswire/ --Lockheed Martin Skunk Works , in partnership with Lockheed Martin's Demonstrations and Prototypes organization and the University of Iowa's Operator Performance Laboratory , showcased a crewed-uncrewed teaming mission where an airborne battle manager issued real-time commands to AI-controlled aircraft through a touchscreen pilot vehicle interface .\"The work we're doing with the University of Iowa's OPL is foundational for the future of air combat, where a family of crewed and uncrewed systems will work together to execute complex missions,\" said John Clark, vice president and general manager, Lockheed Martin Skunk Works. \"We're excited to leverage our diverse skillsets to advance all elements of this new way of operating.\". Skunk Works is dedicated to enabling crewed-uncrewed teaming to optimize operational flexibility, abbreviate data-to-decision timelines and improve pilot safety. We continue to invest in collaborative enablers to keep ou","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4CsfwIYncopQqOLMokLxhg--~B/aD02MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/951a8524e7feb0f8da11bc81e9dfbff2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4CsfwIYncopQqOLMokLxhg--~B/aD02MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/951a8524e7feb0f8da11bc81e9dfbff2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/skunk-works-demonstrates-airborne-battle-170000734.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/skunk-works-demonstrates-airborne-battle-170000734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550221.USD","BK4516","LU1244550494.USD","LU0320765646.SGD","LMT","LU1162221912.USD","BK4588","BK4187","PVI","BK4564","LU1244550577.SGD","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVI\",params:#limit:5,,,undefined,":[{"date":"2025-05-19","symbol":"PVI","amount":0.06158,"announcedDate":"2025-05-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-19","defaultRemindTime":1747661400000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-23","payableDate":"2025-05-19","currency":"USD","dateTimestamp":1747627200000,"payDate":"2025-05-23"},{"date":"2025-04-21","symbol":"PVI","amount":0.04607,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-21","defaultRemindTime":1745242200000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-25","payableDate":"2025-04-21","currency":"USD","dateTimestamp":1745208000000,"payDate":"2025-04-25"},{"date":"2025-03-24","symbol":"PVI","amount":0.03108,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2025-02-24","symbol":"PVI","amount":0.03987,"announcedDate":"2025-02-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-24","defaultRemindTime":1740407400000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-24","currency":"USD","dateTimestamp":1740373200000,"payDate":"2025-02-28"},{"date":"2025-01-21","symbol":"PVI","amount":0.05783,"announcedDate":"2025-01-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-21","defaultRemindTime":1737469800000,"name":"Invesco VRDO Tax-Free ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-24","payableDate":"2025-01-21","currency":"USD","dateTimestamp":1737435600000,"payDate":"2025-01-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVI\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-15","recordDate":"2015-07-17","paymentDate":"2015-07-31","value":0.00005,"currency":"USD"},{"executeDate":"2015-08-14","recordDate":"2015-08-18","paymentDate":"2015-08-31","value":0.00005,"currency":"USD"},{"executeDate":"2015-09-15","recordDate":"2015-09-17","paymentDate":"2015-09-30","value":0.00005,"currency":"USD"},{"executeDate":"2015-10-15","recordDate":"2015-10-19","paymentDate":"2015-10-30","value":0.00005,"currency":"USD"},{"executeDate":"2015-11-13","recordDate":"2015-11-17","paymentDate":"2015-11-30","value":0.00005,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVI\",market:\"US\",delay:false,,,undefined,":{}}}